Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.

MLA

Yonkers, Kimberly A., et al. “Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.” Journal of Clinical Psychopharmacology, vol. 43, no. 4, July 2023, pp. 320–25. EBSCOhost, https://doi.org/10.1097/JCP.0000000000001700.

APA

Yonkers, K. A., Altemus, M., Gilstad-Hayden, K., Kornstein, S. G., & Gueorguieva, R. (2023). Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial. Journal of Clinical Psychopharmacology, 43(4), 320–325. https://doi.org/10.1097/JCP.0000000000001700

Chicago

Yonkers, Kimberly A, Margaret Altemus, Kathryn Gilstad-Hayden, Susan G Kornstein, and Ralitza Gueorguieva. 2023. “Does Symptom-Onset Treatment With Sertraline Improve Functional Impairment for Individuals With Premenstrual Dysphoric Disorder?: A Randomized Controlled Trial.” Journal of Clinical Psychopharmacology 43 (4): 320–25. doi:10.1097/JCP.0000000000001700.